Form 4: HealthStream CFO Scott Roberts Reports Stock Transactions Following RSU Vesting

HealthStream's CFO, Scott Alexander Roberts, reports the acquisition and disposal of company stock following the vesting of restricted share units (RSUs) on February 23, 2024.

Summary

• On February 23, 2024, Scott Alexander Roberts, CFO and SVP of HealthStream Inc., reported transactions involving HealthStream's common stock.
• Roberts acquired 1,500 shares of common stock upon the vesting of restricted share units (RSUs) at a price of $0.
• Simultaneously, Roberts disposed of 364 shares to cover tax liabilities at a price of $26.81 per share.
• Following these transactions, Roberts directly owns 17,035 shares of HealthStream common stock and 8,500 restricted share units.
• The vesting of the RSUs is contingent upon continued service and the achievement of certain performance criteria established annually by the Compensation Committee.
• 15% of the awards vested on February 23, 2024, because the performance criteria for the period January 1, 2023, through December 31, 2023, was achieved.
• The remaining RSUs will vest in installments between 2025 and 2028, contingent on continued service and performance.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs suggests the company met its performance criteria, which is a positive sign. The stock disposal is a routine event for tax purposes and doesn't indicate negative sentiment.

Positives

• The vesting of RSUs indicates that performance criteria were met for the period January 1, 2023, through December 31, 2023, suggesting positive performance by the company.

Negatives

• The disposal of shares to cover tax liabilities, while standard, slightly reduces Roberts' direct holdings in the company.

Risks

• Future vesting of RSUs is contingent on continued service and the achievement of performance criteria, which introduces uncertainty.

Future Outlook

Future RSU vesting is contingent upon continued service and the achievement of performance criteria established annually by the Compensation Committee of the Board of Directors.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of management's interests with those of shareholders.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in the healthcare technology industry, aligning executive incentives with company performance.
• Vesting schedules tied to performance metrics are also standard practice, ensuring executives are rewarded for achieving specific goals.
• Companies like Cerner (now Oracle Health) and Allscripts also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

• The vesting of RSUs aligns management's interests with shareholders, incentivizing them to improve company performance.
• The disclosure provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates